Schneyer Mark C. bought ACAD
August 5, 2026 · Form 4 insider transaction
Schneyer Mark C. bought 5,849 shares of ACADIA Pharmaceuticals Inc. at $17.84 per share, a transaction worth $104.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,849
Price
$17.84
Total value
$104.3K
InsiderSchneyer Mark C.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 5, 2026
Filing dateAugust 7, 2026
Shares owned after73,677
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 1,683 shares of the Issuer's common stock acquired by the reporting person on May 15, 2026 pursuant to an employee stock purchase plan.